Pharmaceutical Industry In East Africa

PHARMACEUTICAL INDUSTRY IN EAST AFRICA, 2007

1

KENYA

PHARMACEUTICAL MARKET OVERVIEW KENYA KENYAN PHARMACEUTICAL MARKET, 2007 USD 210 Mn

MARKET BY SEGMENT

MARKET BY SOURCE BRANDED 44%

GENERIC 56%

DOMESTIC 28%

| CAGR (2007-2014) 15%

KENYAN PHARMACEUTICAL MARKET, 2014 USD 560 Mn

MNC 72%

TANZANIA

PHARMACEUTICAL MARKET OVERVIEW TANZANIA TANZANIA PHARMACEUTICAL MARKET, 2007 USD 105 Mn

MARKET BY SEGMENT

MARKET BY SOURCE BRANDED 46%

GENERIC 54%

DOMESTIC 31%

| CAGR (2007-2014) 9%

TANZANIA PHARMACEUTICAL MARKET, 2014 USD 190 Mn

MNC 69%

UGANDA

PHARMACEUTICAL MARKET OVERVIEW UGANDA UGANDA PHARMACEUTICAL MARKET, 2007 USD 85 Mn

MARKET BY SEGMENT

MARKET BY SOURCE BRANDED 20%

GENERIC 80%

DOMESTIC 10%

| CAGR (2007-2014) 8.5%

UGANDA PHARMACEUTICAL MARKET, 2014 USD 150 Mn

MNC 90%

EAST AFRICA

COUNTRY

KENYA

TANZANIA

UGANDA

REGULATORY FRAMEWORK AND TIME LINE FOR NEW PRODUCT REGISTRATION REGULATORY BODY

The Pharmacy and Poisons Board (PPB)

Tanzania Food and Drugs Authority (TFDA)

National Drug Authority (NDA)

KRAs

Responsible for the registration and quality control of pharmaceuticals, licensing of pharmaceuticals and advertising of drugs.

Responsible for registration and licensing of manufacturing sites, entry ports pharmaceutical and medical device products. • Also regulates import and export of registered products.

TIME LINE

3-6 MONTHS

|

The National Drug Authority (NDA) is an autonomous body set up by the government to implement the National Drug Policy based on the concept of Essential Drugs. NDA is the guardian of public interest concerning drugs. Any drug promotion information reaching the public in Uganda must first be vetted by and obtain approval from NDA.

8-12 MONTHS

8-12 MONTHS

THANK YOU ManasRanjan Rout | Pharmaceutical and Healthcare Professional, Kenya Email: [email protected]